These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
721 related articles for article (PubMed ID: 19374402)
1. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening. Klabunde T; Giegerich C; Evers A J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402 [TBL] [Abstract][Full Text] [Related]
2. An automated system for the analysis of G protein-coupled receptor transmembrane binding pockets: alignment, receptor-based pharmacophores, and their application. Kratochwil NA; Malherbe P; Lindemann L; Ebeling M; Hoener MC; Mühlemann A; Porter RH; Stahl M; Gerber PR J Chem Inf Model; 2005; 45(5):1324-36. PubMed ID: 16180909 [TBL] [Abstract][Full Text] [Related]
3. PREDICT modeling and in-silico screening for G-protein coupled receptors. Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594 [TBL] [Abstract][Full Text] [Related]
4. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols. Evers A; Hessler G; Matter H; Klabunde T J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144 [TBL] [Abstract][Full Text] [Related]
5. Drug design strategies for targeting G-protein-coupled receptors. Klabunde T; Hessler G Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358 [TBL] [Abstract][Full Text] [Related]
6. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets? Bissantz C; Bernard P; Hibert M; Rognan D Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595 [TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Kristiansen K Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227 [TBL] [Abstract][Full Text] [Related]
8. Virtual screen for ligands of orphan G protein-coupled receptors. Bock JR; Gough DA J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917 [TBL] [Abstract][Full Text] [Related]
9. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring. Radestock S; Weil T; Renner S J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221 [TBL] [Abstract][Full Text] [Related]
10. Snooker: a structure-based pharmacophore generation tool applied to class A GPCRs. Sanders MP; Verhoeven S; de Graaf C; Roumen L; Vroling B; Nabuurs SB; de Vlieg J; Klomp JP J Chem Inf Model; 2011 Sep; 51(9):2277-92. PubMed ID: 21866955 [TBL] [Abstract][Full Text] [Related]
11. Recognition of privileged structures by G-protein coupled receptors. Bondensgaard K; Ankersen M; Thøgersen H; Hansen BS; Wulff BS; Bywater RP J Med Chem; 2004 Feb; 47(4):888-99. PubMed ID: 14761190 [TBL] [Abstract][Full Text] [Related]
12. Modeling small molecule-compound binding to G-protein-coupled receptors. Vaidehi N; Pease JE; Horuk R Methods Enzymol; 2009; 460():263-88. PubMed ID: 19446730 [TBL] [Abstract][Full Text] [Related]
13. High-throughput modeling of human G-protein coupled receptors: amino acid sequence alignment, three-dimensional model building, and receptor library screening. Bissantz C; Logean A; Rognan D J Chem Inf Comput Sci; 2004; 44(3):1162-76. PubMed ID: 15154786 [TBL] [Abstract][Full Text] [Related]
14. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise. Yarnitzky T; Levit A; Niv MY Curr Opin Drug Discov Devel; 2010 May; 13(3):317-25. PubMed ID: 20443165 [TBL] [Abstract][Full Text] [Related]
15. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model. Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194 [TBL] [Abstract][Full Text] [Related]
16. Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening. Renner S; Schneider G J Med Chem; 2004 Sep; 47(19):4653-64. PubMed ID: 15341481 [TBL] [Abstract][Full Text] [Related]
17. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery. Huber T; Menon S; Sakmar TP Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775 [TBL] [Abstract][Full Text] [Related]
18. Ligand-steered modeling and docking: A benchmarking study in class A G-protein-coupled receptors. Phatak SS; Gatica EA; Cavasotto CN J Chem Inf Model; 2010 Dec; 50(12):2119-28. PubMed ID: 21080692 [TBL] [Abstract][Full Text] [Related]
19. Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor. Miller LJ; Dong M; Harikumar KG; Gao F Biochem Soc Trans; 2007 Aug; 35(Pt 4):709-12. PubMed ID: 17635130 [TBL] [Abstract][Full Text] [Related]
20. Molecular modeling of the second extracellular loop of G-protein coupled receptors and its implication on structure-based virtual screening. de Graaf C; Foata N; Engkvist O; Rognan D Proteins; 2008 May; 71(2):599-620. PubMed ID: 17972285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]